Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho
Detection Principle
ImmunoAssay-Antibody
Target
IgG on N protein
Testing Method Category
Testing Method
chemiluminescent microparticle immunoassay
Testing Method - Additional Info
Abbott SARS-CoV-2 IgG test
Reported Performance
specificity: 99.90%; sensitivity: 53.1% (7 dpo), 82.4% (10 dpo), 96.9% (14 dpo),100% (17 dpo), 88.7% (7 days post PCR positivity), 97.2% (10 days post PCR positivity), 100% (>14 days post PCR positivity)
Sample Size
6001 samples (1145 for validation, 4856 for seroprevalence survey)
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements